subjects-adv.jpg
48 of 82
Fibrin Contributes to an Improvement of an in vitro Wound Repair Model using Fibroblast-populated Collagen Lattices
Mario Chopin-DoroteoAldo Montes de Oca-Delgado, Rosa M Salgado and Edgar Krötzsch
50 of 82
Preventing Rectal Toxicity in Prostate Cancer: Diet and Supplement Alternative to Enemas or Rectal Spacer
Fabrizio Piro, Daria Cosentino, Ugo Piro, Gabriella Tocci and Luigi Marafioti
Abstract

Abstract at IgMin Research

Our mission is to foster interdisciplinary dialogue and accelerate the advancement of knowledge across a wide spectrum of scientific domains.

Breast Cancer: The Road to a Personalized Prevention

Affiliation

Affiliation

    Interdisciplinary Department of Medicine, Section of Diagnostic Imaging, University of Bari Medical School “Aldo Moro”, Piazza Giulio Cesare 11, Bari, 70124, Italy

    University of Rome Tor Vergata, Department of Chemical Sciences and Technologies, Via della Ricerca Scientifica 1, 00133, Rome, Italy

    University of Rome Tor Vergata, Department of Chemical Sciences and Technologies, Via della Ricerca Scientifica 1, 00133, Rome, Italy

Abstract

Breast cancer is the most common type of cancer in women worldwide. It can be spread when cancer cells get into the blood or lymph system and then are carried to other parts of the body. As it is one of the leading causes of death among women, this study aims to identify the most relevant risk factors for breast cancer through several prevention methods for early detection. The social impact of breast cancer is so strong that the World Health Organization (WHO) has established 19 October as International Breast Cancer Day. The pink ribbon is the symbol of this important day worldwide. The objective is precisely to raise awareness among the population about the disease and promote access to timely and effective diagnoses, checks, and treatments.
Good prevention should be carried out through behavior or lifestyle modifications (e.g., diet, physical activity, alcohol limitation, etc.). Although, certain risk factors cannot be modified (e.g., aging, family history). Screenings are a fundamental tool to deal with breast cancer, even if sometimes they are not enough as in the case of interval cancers or in cases of particularly ambiguous presentation. Worldwide organizations recommend screening by means of ultrasound, mammography, and magnetic resonance, with appropriate follow-up for an abnormal screening test. To avoid overdiagnosis and overtreatment that can lead to long-term complications and false negatives, these screening differs by recommended ages and frequency. Identification of women at risk for BRCA1 and BRCA2 mutations is also recommended with a referral for genetic testing and, in the presence of dubious lesions, a biopsy is needed. In order to fight this disease, is important to act on time, so, information is fundamental. First of all, the female population should be conscious of risk factors and of the importance of breast examinations from a young age, lastly, they should be aware of the possibility of joining programs of free screening.

Figures

References

    1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2. PMID: 36084384; PMCID: PMC9465273.
    2. Mayrovitz HN, editor. Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. PMID: 36121977.
    3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12. PMID: 35020204.
    4. Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys. 2015 Jun;72(2):333-8. doi: 10.1007/s12013-014-0459-6. PMID: 25543329.
    5. Lumachi F, Ermani M, Basso S. (2023). ISBN: 8879998609.
    6. Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. Risk Factors and Preventions of Breast Cancer. Int J Biol Sci. 2017 Nov 1;13(11):1387-1397. doi: 10.7150/ijbs.21635. PMID: 29209143; PMCID: PMC5715522.
    7. Gompel A. Hormones et cancers du sein [Hormone and breast cancer]. Presse Med. 2019 Oct;48(10):1085-1091. French. doi: 10.1016/j.lpm.2019.09.021. Epub 2019 Oct 26. PMID: 31662219.
    8. Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020 Aug;20(8):417-436. doi: 10.1038/s41568-020-0266-x. Epub 2020 Jun 11. PMID: 32528185.
    9. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002 Jul 20;360(9328):187-95. doi: 10.1016/S0140-6736(02)09454-0. PMID: 12133652.
    10. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008 Aug;67(3):253-6. doi: 10.1017/S002966510800712X. Epub 2008 May 1. PMID: 18452640.
    11. Frydenberg H, Flote VG, Larsson IM, Barrett ES, Furberg AS, Ursin G, Wilsgaard T, Ellison PT, McTiernan A, Hjartåker A, Jasienska G, Thune I. Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women. Breast Cancer Res. 2015 Aug 7;17(1):103. doi: 10.1186/s13058-015-0620-1. PMID: 26246001; PMCID: PMC4531831.
    12. Macacu A, Autier P, Boniol M, Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat. 2015 Nov;154(2):213-24. doi: 10.1007/s10549-015-3628-4. Epub 2015 Nov 6. PMID: 26546245.
    13. Ng AK, Travis LB. Radiation therapy and breast cancer risk. J Natl Compr Canc Netw. 2009 Nov;7(10):1121-8. doi: 10.6004/jnccn.2009.0073. PMID: 19930978.
    14. Eidemüller M, Holmberg E, Lundell M, Karlsson P. Evidence for Increased Susceptibility to Breast Cancer From Exposure to Ionizing Radiation Due to a Familial History of Breast Cancer: Results From the Swedish Hemangioma Cohort. Am J Epidemiol. 2021 Jan 4;190(1):76-84. doi: 10.1093/aje/kwaa163. PMID: 32735015; PMCID: PMC7784527.
    15. Taparra K, Miller RC, Deville C Jr. Navigating Native Hawaiian and Pacific Islander Cancer Disparities From a Cultural and Historical Perspective. JCO Oncol Pract. 2021 Mar;17(3):130-134. doi: 10.1200/OP.20.00831. Epub 2021 Jan 26. PMID: 33497251.
    16. Medina HN, Callahan KE, Morris CR, Thompson CA, Siweya A, Pinheiro PS. Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California. Cancer Epidemiol Biomarkers Prev. 2021 Jul;30(7):1387-1396. doi: 10.1158/1055-9965.EPI-20-1528. Epub 2021 Apr 20. PMID: 33879454; PMCID: PMC8254771.
    17. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3. PMID: 36190501.
    18. Al-Amri AM. Prevention of breast cancer. J Family Community Med. 2005 May;12(2):71-4. PMID: 23012078; PMCID: PMC3410124.
    19. American Cancer Society (1990). Cancer Facts and Figures. Atlanta American Cancer Society, USA, 56.
    20. Lundberg P, Forsgren MF, Tellman J, Kihlberg J, Rzepecka A, Dabrosin C. Breast density is strongly associated with multiparametric magnetic resonance imaging biomarkers and pro-tumorigenic proteins in situ. Br J Cancer. 2022 Nov;127(11):2025-2033. doi: 10.1038/s41416-022-01976-3. Epub 2022 Sep 22. PMID: 36138072; PMCID: PMC9681775.
    21. Sood R, Rositch AF, Shakoor D, Ambinder E, Pool KL, Pollack E, Mollura DJ, Mullen LA, Harvey SC. Ultrasound for Breast Cancer Detection Globally: A Systematic Review and Meta-Analysis. J Glob Oncol. 2019 Aug;5:1-17. doi: 10.1200/JGO.19.00127. PMID: 31454282; PMCID: PMC6733207.
    22. Heywang-Köbrunner SH, Hacker A, Sedlacek S. Advantages and Disadvantages of Mammography Screening. Breast Care (Basel). 2011;6(3):199-207. doi: 10.1159/000329005. Epub 2011 May 27. PMID: 21779225; PMCID: PMC3132967.
    23. Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, Törnberg S, Chen SL, Chiu SY, Fann JC, Ku MM, Wu WY, Hsu CY, Chen YC, Svane G, Azavedo E, Grundström H, Sundén P, Leifland K, Frodis E, Ramos J, Epstein B, Åkerlund A, Sundbom A, Bordás P, Wallin H, Starck L, Björkgren A, Carlson S, Fredriksson I, Ahlgren J, Öhman D, Holmberg L, Chen TH. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. Cancer. 2020 Jul 1;126(13):2971-2979. doi: 10.1002/cncr.32859. Epub 2020 May 11. PMID: 32390151; PMCID: PMC7318598.
    24. Suleiman ME, Brennan PC, McEntee MF. Mean glandular dose in digital mammography: a dose calculation method comparison. J Med Imaging (Bellingham). 2017 Jan;4(1):013502. doi: 10.1117/1.JMI.4.1.013502. Epub 2017 Jan 24. PMID: 28149921; PMCID: PMC5260632.
    25. ACR Appropriateness Criteria. https://www.acr. org/Clinical-Resources/ACR-Appropriateness-Criteria. Accessed February 28, 2021.
    26. Chen T, Kharazmi E, Fallah M. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw Open. 2023 Apr 3;6(4):e238893. doi: 10.1001/jamanetworkopen.2023.8893. PMID: 37074714; PMCID: PMC10116360.
    27. Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414. doi: 10.1016/j.jacr.2017.11.034. Epub 2018 Jan 19. PMID: 29371086.
    28. Gordon PB. The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening. Curr Oncol. 2022 May 17;29(5):3595-3636. doi: 10.3390/curroncol29050291. PMID: 35621681; PMCID: PMC9140155.
    29. Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, Böhm-Vélez M, Mahoney MC, Evans WP 3rd, Larsen LH, Morton MJ, Mendelson EB, Farria DM, Cormack JB, Marques HS, Adams A, Yeh NM, Gabrielli G; ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012 Apr 4;307(13):1394-404. doi: 10.1001/jama.2012.388. PMID: 22474203; PMCID: PMC3891886.
    30. Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea MK, Rudas M, Singer CF, Helbich TH. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015 Apr 1;33(10):1128-35. doi: 10.1200/JCO.2014.56.8626. Epub 2015 Feb 23. PMID: 25713430; PMCID: PMC5526626.
    31. Vreemann S, van Zelst JCM, Schlooz-Vries M, Bult P, Hoogerbrugge N, Karssemeijer N, Gubern-Mérida A, Mann RM. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI. Breast Cancer Res. 2018 Aug 3;20(1):84. doi: 10.1186/s13058-018-1019-6. PMID: 30075794; PMCID: PMC6091096.
    32. Sung JS, Stamler S, Brooks J, Kaplan J, Huang T, Dershaw DD, Lee CH, Morris EA, Comstock CE. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results. Radiology. 2016 Sep;280(3):716-22. doi: 10.1148/radiol.2016151419. Epub 2016 Apr 20. PMID: 27097237; PMCID: PMC5006733.
    33. Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk. JAMA Intern Med. 2019 May 1;179(5):658-667. doi: 10.1001/jamainternmed.2018.8372. Erratum in: JAMA Intern Med. 2019 Apr 29;: PMID: 30882843; PMCID: PMC6503561.
    34. Ożegalska-Trybalska J. Plagiarism and self-plagiarism – facts and myths. Nowotwory. Journal of Oncology. 2021; 71(1): 71–72. doi: 10.5603/ NJO.2021.0012.
    35. Saccarelli CR, Bitencourt AGV, Morris EA. Breast Cancer Screening in High-Risk Women: Is MRI Alone Enough? J Natl Cancer Inst. 2020 Feb 1;112(2):121-122. doi: 10.1093/jnci/djz130. PMID: 31233125; PMCID: PMC7019094.
    36. Engel C, Fischer C. Breast cancer risks and risk prediction models. Breast Care (Basel). 2015 Feb;10(1):7-12. doi: 10.1159/000376600. PMID: 25960719; PMCID: PMC4395818.
    37. Taylor MR. Genetic testing for inherited breast and ovarian cancer syndromes: important concepts for the primary care physician. Postgrad Med J. 2001 Jan;77(903):11-5. doi: 10.1136/pmj.77.903.11. PMID: 11123386; PMCID: PMC1741878.
    38. Guo R, Lu G, Qin B, Fei B. Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review. Ultrasound Med Biol. 2018 Jan;44(1):37-70. doi: 10.1016/j.ultrasmedbio.2017.09.012. Epub 2017 Oct 26. PMID: 29107353; PMCID: PMC6169997.
    39. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004 Mar 15;22(6):1055-62. doi: 10.1200/JCO.2004.04.188. Epub 2004 Feb 23. PMID: 14981104.
    40. Andresen SL. John McCarthy: father of AI. IEEE Intelligent Systems 2002; 17:84-5.
    41. McCarthy J. The Dartmouth summer research project on artificial intelligence. Artificial intelligence: past, present, and future. 1956.
    42. Choi RY, Coyner AS, Kalpathy-Cramer J, Chiang MF, Campbell JP. Introduction to Machine Learning, Neural Networks, and Deep Learning. Transl Vis Sci Technol. 2020 Feb 27;9(2):14. doi: 10.1167/tvst.9.2.14. PMID: 32704420; PMCID: PMC7347027.
    43. Guerranti R, Padoan A, Angeletti D, Foracchia M. Introduzione ai big data e all’Intelligenza artificiale in medicina di laboratorio. Biochim Clin. 2021; 45: 57-67.
    44. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015 May 28;521(7553):436-44. doi: 10.1038/nature14539. PMID: 26017442.
    45. Reiner B. Contextualizing Causation of Uncertainty in Medical Reporting. J Am Coll Radiol. 2018 Feb;15(2):325-327. doi: 10.1016/j.jacr.2017.08.019. Epub 2017 Sep 22. PMID: 28958724.
    46. Sabottke CF, Spieler BM. The Effect of Image Resolution on Deep Learning in Radiography. Radiol Artif Intell. 2020 Jan 22;2(1):e190015. doi: 10.1148/ryai.2019190015. PMID: 33937810; PMCID: PMC8017385.
    47. Jalalian A, Mashohor S, Mahmud R, Karasfi B, Saripan MIB, Ramli ARB. Foundation and methodologies in computer-aided diagnosis systems for breast cancer detection. EXCLI J. 2017 Feb 20;16:113-137. doi: 10.17179/excli2016-701. PMID: 28435432; PMCID: PMC5379115.
    48. Ou WC, Polat D, Dogan BE. Deep learning in breast radiology: current progress and future directions. Eur Radiol. 2021 Jul;31(7):4872-4885. doi: 10.1007/s00330-020-07640-9. Epub 2021 Jan 15. PMID: 33449174.
    49. Kohli A, Jha S. Why CAD Failed in Mammography. J Am Coll Radiol. 2018 Mar;15(3 Pt B):535-537. doi: 10.1016/j.jacr.2017.12.029. Epub 2018 Feb 3. PMID: 29398499.
    50. Chan HP, Hadjiiski LM, Samala RK. Computer-aided diagnosis in the era of deep learning. Med Phys. 2020 Jun;47(5):e218-e227. doi: 10.1002/mp.13764. PMID: 32418340; PMCID: PMC7293164.
    51. Alsharif WM. The utilization of artificial intelligence applications to improve breast cancer detection and prognosis. Saudi Med J. 2023 Feb;44(2):119-127. doi: 10.15537/smj.2023.44.2.20220611. PMID: 36773967; PMCID: PMC9987701.
    52. Farkas A, Vanderberg R, Merriam S, DiNardo D. Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider. J Womens Health (Larchmt). 2020 Jan;29(1):46-56. doi: 10.1089/jwh.2018.7643. Epub 2019 Sep 27. PMID: 31560601.
    53. National Cancer Institute. National Cancer Institute Fact Sheet: Breast cancer risk in American women. http://www.cancer.gov/cancertopics/ factsheet/detection/probability-breast-cancer.
    54. Smith SG, Foy R, McGowan JA, Kobayashi LC, de Censi A, DeCensi A, Brown K, Side L, Cuzick J. Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes. Br J Gen Pract. 2017 Jun;67(659):e414-e427. doi: 10.3399/bjgp17X689377. Epub 2017 Feb 13. Erratum in: Br J Gen Pract. 2018 Oct;68(675):468. DeCensi A [corrected to de Censi A]. PMID: 28193617; PMCID: PMC5442957.
    55. Bidassie B, Kovach A, Vallette MA, Merriman J, Park YA, Aggarwal A, Colonna S. Breast Cancer Risk Assessment and Chemoprevention Use Among Veterans Affairs Primary Care Providers: A National Online Survey. Mil Med. 2020 Mar 2;185(3-4):512-518. doi: 10.1093/milmed/usz291. PMID: 31865375.
    56. Lee SI, Curtis H, Qureshi S, et al. Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England. J Community Genet. 2021; 12(1):111–20.
    57. Kyalwazi B, Yau C, Campbell MJ, Yoshimatsu TF, Chien AJ, Wallace AM, Forero-Torres A, Pusztai L, Ellis ED, Albain KS, Blaes AH, Haley BB, Boughey JC, Elias AD, Clark AS, Isaacs CJ, Nanda R, Han HS, Yung RL, Tripathy D, Edmiston KK, Viscusi RK, Northfelt DW, Khan QJ, Asare SM, Wilson A, Hirst GL, Lu R, Symmans WF, Yee D, DeMichele AM, van 't Veer LJ, Esserman LJ, Olopade OI. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. JAMA Netw Open. 2023 Dec 1;6(12):e2349646. doi: 10.1001/jamanetworkopen.2023.49646. PMID: 38153734; PMCID: PMC10755617.
    58. Omilian AR, Wei L, Hong CC, Bandera EV, Liu S, Khoury T, Ambrosone CB, Yao S. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women. Breast Cancer Res Treat. 2020 Jul;182(2):503-509. doi: 10.1007/s10549-020-05693-4. Epub 2020 May 21. PMID: 32441016; PMCID: PMC7313393.

Similar Articles

Diagnostic Challenges in Pancreatic Tumors
Ionuţ Simion ComanElena Violeta Coman, Costin George Florea, Teodora Elena Tudose, Cosmin Burleanu, Anwar Erchid and Valentin Titus Grigorean
DOI10.61927/igmin185